These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 25400129)

  • 1. Evaluation of polymeric nanoparticle formulations by effective imaging and quantitation of cellular uptake for controlled delivery of doxorubicin.
    Win KY; Teng CP; Ye E; Low M; Han MY
    Small; 2015 Mar; 11(9-10):1197-204. PubMed ID: 25400129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering polymeric microparticles as theranostic carriers for selective delivery and cancer therapy.
    Win KY; Ye E; Teng CP; Jiang S; Han MY
    Adv Healthc Mater; 2013 Dec; 2(12):1571-5. PubMed ID: 23712912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodegradable polymeric vesicles containing magnetic nanoparticles, quantum dots and anticancer drugs for drug delivery and imaging.
    Ye F; Barrefelt A; Asem H; Abedi-Valugerdi M; El-Serafi I; Saghafian M; Abu-Salah K; Alrokayan S; Muhammed M; Hassan M
    Biomaterials; 2014 Apr; 35(12):3885-94. PubMed ID: 24495486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surfactant-free, drug-quantum-dot coloaded poly(lactide-co-glycolide) nanoparticles: towards multifunctional nanoparticles.
    Nehilla BJ; Allen PG; Desai TA
    ACS Nano; 2008 Mar; 2(3):538-44. PubMed ID: 19206580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery.
    Parveen S; Sahoo SK
    Eur J Pharmacol; 2011 Nov; 670(2-3):372-83. PubMed ID: 21951969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of 3-D tumor spheroids by timed-released hydrophilic and hydrophobic drugs from multilayered polymeric microparticles.
    Lee WL; Guo WM; Ho VH; Saha A; Chong HC; Tan NS; Widjaja E; Tan EY; Loo SC
    Small; 2014 Oct; 10(19):3986-96. PubMed ID: 24947558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of the preparation of organic polymeric nanoparticles for drug delivery based on gelatine, chitosan, poly(d,l-lactide-co-glycolic acid) and polyalkylcyanoacrylate.
    Lai P; Daear W; Löbenberg R; Prenner EJ
    Colloids Surf B Biointerfaces; 2014 Jun; 118():154-63. PubMed ID: 24769392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
    Yu JM; Li YJ; Qiu LY; Jin Y
    J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow Focusing: a versatile technology to produce size-controlled and specific-morphology microparticles.
    Martín-Banderas L; Flores-Mosquera M; Riesco-Chueca P; Rodríguez-Gil A; Cebolla A; Chávez S; Gañán-Calvo AM
    Small; 2005 Jul; 1(7):688-92. PubMed ID: 17193506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using Peptide Aptamer Targeted Polymers as a Model Nanomedicine for Investigating Drug Distribution in Cancer Nanotheranostics.
    Zhao Y; Houston ZH; Simpson JD; Chen L; Fletcher NL; Fuchs AV; Blakey I; Thurecht KJ
    Mol Pharm; 2017 Oct; 14(10):3539-3549. PubMed ID: 28880092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using fluorescence lifetime imaging microscopy to monitor theranostic nanoparticle uptake and intracellular doxorubicin release.
    Basuki JS; Duong HT; Macmillan A; Erlich RB; Esser L; Akerfeldt MC; Whan RM; Kavallaris M; Boyer C; Davis TP
    ACS Nano; 2013 Nov; 7(11):10175-89. PubMed ID: 24131276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin E TPGS-emulsified poly(lactic-co-glycolic acid) nanoparticles for cardiovascular restenosis treatment.
    Feng SS; Zeng W; Teng Lim Y; Zhao L; Yin Win K; Oakley R; Hin Teoh S; Hang Lee RC; Pan S
    Nanomedicine (Lond); 2007 Jun; 2(3):333-44. PubMed ID: 17716178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymeric-gold nanohybrids for combined imaging and cancer therapy.
    Topete A; Alatorre-Meda M; Villar-Alvarez EM; Carregal-Romero S; Barbosa S; Parak WJ; Taboada P; Mosquera V
    Adv Healthc Mater; 2014 Aug; 3(8):1309-25. PubMed ID: 24764284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifunctional silica nanoparticles for targeted delivery of hydrophobic imaging and therapeutic agents.
    Liu Y; Mi Y; Zhao J; Feng SS
    Int J Pharm; 2011 Dec; 421(2):370-8. PubMed ID: 22001536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis.
    Ohashi K; Kabasawa T; Ozeki T; Okada H
    J Control Release; 2009 Apr; 135(1):19-24. PubMed ID: 19121349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifunctional core-shell polymeric nanoparticles for transdermal DNA delivery and epidermal Langerhans cells tracking.
    Lee PW; Hsu SH; Tsai JS; Chen FR; Huang PJ; Ke CJ; Liao ZX; Hsiao CW; Lin HJ; Sung HW
    Biomaterials; 2010 Mar; 31(8):2425-34. PubMed ID: 20034662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y; Pan J; Feng SS
    Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine.
    Al-Jamal WT; Kostarelos K
    Acc Chem Res; 2011 Oct; 44(10):1094-104. PubMed ID: 21812415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.